P

Prothena Corp

D

PRTA

USD

0.18

(0.8372%)

Market Closed

18,984.00

حجم التداول

-2.245

الربح لكل سهم

-

العائد الربحي

-23.063830

P/E

1,165,957,879.60

حجم السوق

اليوم

0.8372%

1 اسبوع

4.734%

1 شهر

2.264%

6 اشهر

-13.591%

12 اشهر

-58.744%

بداية السنة

-40.374%

كل الوقت

-63.879%

أصول ذات صلة

Title:
Prothena Corp

Sector:

Healthcare

Industry:

Biotechnology

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا